Table 1.
Patient, treatment, and clinical characteristics for the study cohort
| Parameter | Number (%) or median (range) |
|---|---|
| Patients | 56 |
| Sex | |
| Female | 36 (64.3) |
| Male | 20 (35.7) |
| Age, y | 65 (45-86) |
| Race | |
| White | 53 (94.6) |
| Black | 2 (3.6) |
| Asian-Pacific | 1 (1.8) |
| KPS index | 90 (60-100) |
| COPD | |
| Yes | 29 (51.8) |
| No | 27 (48.2) |
| Smoking status | |
| Nonsmoker | 3 (5.4) |
| Current smoker | 14 (25) |
| Former smoker | 39 (69.6) |
| Type of lung cancer | |
| NSCLC | 46 (82.1) |
| SCLC | 10 (17.9) |
| Stage | |
| I | 2 (3.6) |
| II | 5 (8.9) |
| III | 43 (76.8) |
| IV | 6 (10.7) |
| Surgery | |
| Yes | 7 (12.5) |
| Lobectomy | 6 (10.7) |
| Pneumonectomy | 1 (1.8) |
| No | 49 (87.5) |
| Chemotherapy | |
| Concurrent | 50 (89.3) |
| Sequential | 2 (3.6) |
| Induction | 4 (7.1) |
| Immunotherapy | |
| Yes | 17 (30.4) |
| No | 39 (69.6) |
| Radiation prescription | |
| Total dose, Gy | 60 (45-66) |
| Number of fractions | 30 (23-33) |
| Fractionation pattern | |
| Daily | 49 (87.5) |
| Twice daily | 7 (12.5) |
Abbreviations: COPD = chronic obstructive pulmonary disease; KPS = Karnofsky Performance Status; NSCLC = non-small cell lung cancer; SCLC = small cell lung cancer.